ML-192
ML-192
ML-192 is a chemical compound that has garnered interest in the field of medical research due to its potential therapeutic applications. This article provides a comprehensive overview of ML-192, including its chemical properties, mechanism of action, and potential uses in medicine.
Chemical Properties
ML-192 is a small molecule inhibitor with the chemical formula C₁₉H₁₈N₂O₃. It is characterized by its aromatic structure and the presence of functional groups that contribute to its biological activity. The compound is synthesized through a series of organic reactions, which involve the formation of key intermediates that are subsequently modified to yield the final product.
Mechanism of Action
ML-192 functions primarily as an inhibitor of the enzyme PARP1 (Poly (ADP-ribose) polymerase 1). PARP1 is involved in the repair of single-strand DNA breaks through the base excision repair pathway. By inhibiting PARP1, ML-192 prevents the repair of DNA damage, leading to the accumulation of DNA breaks and ultimately cell death. This mechanism is particularly effective in cancer cells that rely heavily on PARP1 for survival.
Therapeutic Applications
ML-192 has shown promise in preclinical studies as a potential treatment for various types of cancer, including breast cancer, ovarian cancer, and prostate cancer. Its ability to selectively target cancer cells while sparing normal cells makes it an attractive candidate for further development. Additionally, ML-192 is being investigated for its role in enhancing the efficacy of existing chemotherapeutic agents by sensitizing cancer cells to DNA-damaging treatments.
Research and Development
Ongoing research is focused on optimizing the pharmacokinetic properties of ML-192 to improve its bioavailability and reduce potential side effects. Clinical trials are being designed to evaluate the safety and efficacy of ML-192 in human subjects, with the aim of advancing it through the drug development pipeline.
Also see
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD